Remove trisalus-inks-spac-merger-fund-cancer-trials-pressure-enabled-drug-delivery-technology
article thumbnail

TriSalus inks SPAC merger to fund cancer trials of pressure-enabled drug delivery technology

Fierce Pharma

TriSalus inks SPAC merger to fund cancer trials of pressure-enabled drug delivery technology. Tue, 11/15/2022 - 10:03.

100
100